Contact
searchSearch
HMP Global
Teaching Collection

The Regurgitant Aortic Valve

Morton J. Kern, MD, MSCAI, FACC, FAHA
01/10/2022

Related Content

Ultrasound
Bracco Marks Major Global Milestone with U.S. FDA 510(k) Clearance and Health Canada Authorization for VueJect, the First Dedicated Ultrasound Contrast Delivery System to Support Cardiology Imaging
08/12/2026
VueJect® strengthens Bracco's integrated contrast-enhanced ultrasound (CEUS) ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging.
VueJect® strengthens Bracco's integrated contrast-enhanced ultrasound (CEUS) ecosystem by enabling more standardized, efficient contrast administration in cardiology imaging.
VueJect® strengthens Bracco's...
08/12/2026
Cath Lab Digest
Valve Disease
Serotonin Pathway Linked to Faster Progression of Degenerative Mitral Regurgitation
07/15/2026
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve. The...
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve. The...
Serotonin is usually associated...
07/15/2026
Cath Lab Digest
Heart Valve Devices
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
06/29/2026
Edwards Lifesciences announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and...
Edwards Lifesciences announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and...
Edwards Lifesciences announced...
06/29/2026
Cath Lab Digest
Aortic Stenosis
Thubrikar Aortic Valve Partners With MAC’s MEDICAL Group and Expands the TAVI-1 CE Mark Trial of the Optimum TAVI System™
06/29/2026
To date, the Optimum TAV has been successfully implanted in 16 patients, with the global FIH patient doing well at 7 years.
To date, the Optimum TAV has been successfully implanted in 16 patients, with the global FIH patient doing well at 7 years.
To date, the Optimum TAV has...
06/29/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

2027 ASC Payments
ASCA Demands That CMS Address ASC Payment Cuts in 2027 Proposed Rule
09/03/2026
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate Medicare payments for cardiovascular procedures performed in ASCs would increase 5% in 2027, compared with a 2% increase across ASC services overall, reflecting in part the relatively high proportion of...
CMS estimates that aggregate...
09/03/2026
Cath Lab Digest
ViV TAVR
Medtronic Announces Strategic Investment in Pi-Cardia to Accelerate Innovation for Complex TAVR
09/02/2026
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is the first FDA-cleared leaflet modification technology designed to enable valve-in-valve TAVR procedures in patients at risk of coronary obstruction.
Pi-Cardia's ShortCut™ device is...
09/02/2026
Cath Lab Digest
Medicare Reimbursement
CMS Approves New Technology Add-on Payment for Reflow Medical’s Spur® Peripheral Retrievable Stent System
09/01/2026
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1, 2026 – Reflow Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has granted the Spur Peripheral Retrievable Stent System a New Technology Add-on Payment (NTAP), providing...
SAN CLEMENTE, CA – September 1,...
09/01/2026
Vascular Disease Management
Risk Reduction
Statins in Reducing Events in the Elderly (STAREE) Trial: Statins Reduce Heart Attack and Stroke Risk in Older People By 30 Percent
09/01/2026
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial conducted by Monash University researchers has shown that cholesterol-lowering medication can reduce heart attack and stroke in people aged over 70 years. 
A world-first clinical trial...
09/01/2026
Cath Lab Digest
Coronary CT
Independent Oxford-Led Data Showcase Value of Coronary Inflammation Assessment in Non-Contrast Cardiac CT, Identifying Risk Even in Patients With Zero Coronary Calcium
09/01/2026
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo Diagnostics, a global leader in AI technologies for cardiovascular disease, announced new independent University of Oxford-led research presented at the European Society of Cardiology (ESC) Congress 2026 showing that...
MUNICH -- Caristo...
09/01/2026
Cath Lab Digest
Heart Failure
New Treatment Administered During Balloon Angioplasty May Reduce the Risk of Heart Failure After a Heart Attack
09/01/2026
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart attack will later develop heart failure due to the scarring that occurs as the heart heals. Researchers at Uppsala University are now presenting a new type of biological treatment that is administered directly...
Many people who survive a heart...
09/01/2026
Cath Lab Digest
Pulmonary Embolism
PRAGUE-26 Trial: Evaluating Catheter-Directed Thrombolysis for Intermediate-High Risk Pulmonary Embolism Patients Versus Standard Anticoagulation Therapy Alone
09/01/2026
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial aimed to challenge the current standard of care in intermediate–high risk acute pulmonary embolism by determining whether conventional CDT (without ultrasound facilitation) can improve on anticoagulation...
“The academic PRAGUE-26 trial...
09/01/2026
Cath Lab Digest
Out-of-Hospital Cardiac Arrest
DISCO Trial: Should Patients With Out-of-Hospital Cardiac Arrest and Without ECG ST-Elevation Receive Immediate Coronary Angiography?
09/01/2026
Key takeaways  Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
Key takeaways  Whether immediate coronary angiography should be performed routinely in unconscious patients without an ECG ST-elevation after out-of-hospital cardiac arrest is uncertain due to the lack of data...
Key...
09/01/2026
Cath Lab Digest
Intravascular Imaging
ISOLEDS Trial: IVUS and OCT Equally as Effective to Guide Complex Stenting in Left Main Disease
09/01/2026
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
The open-label, noninferiority ISOLEDS trial enrolled 664 patients with true distal left main bifurcation lesions at 24 centres in China and randomised them (1:1) to OCT- or IVUS-guided PCI.
The open-label, noninferiority...
09/01/2026
Cath Lab Digest
Revascularization Strategy
EVAOLD Trial Provides Guidance on Treating Older Patients Experiencing NSTEMI
09/01/2026
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
This open-label noninferiority trial was conducted at 25 French centres. Patients aged 80 years or older who were hospitalised with NSTEMI were included. They were randomised to receive either stress imaging-guided selective invasive...
This open-label noninferiority...
09/01/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use